Observational Study of Switching from Natalizumab to Immunomodulatory Drugs

2017

Objective: To determine the effect of disease-modifying drugs (DMDs) on disease activity rebound in patients discontinuing natalizumab (NTZ). Me

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

52

References

10

Citations